Labeling & Serialization

We integrate labeling and serialization directly within manufacturing execution to support compliant commercial supply.

Drug Manufacturing banner

Labeling & Serialization for Global Supply

We offer coordinated artwork integration, compliant labeling, and robust serialization to support accurate product identification, global traceability, and reliable batch release.

Labeling and serialization are critical GMP operations that directly impact market access, traceability, and supply reliability. Groupe PARIMA provides integrated labeling, serialization, and artwork coordination services designed to align regulatory requirements with manufacturing execution, ensuring readiness for commercial distribution across multiple markets.

Artwork Coordination

We coordinate artwork through defined proofing and approval workflows to support compliant labeling.

Labeling Solutions

We manage GMP‑controlled labeling operations to support accurate product identification.

Serialization and Aggregation

Our capabilities support global regulations, enabling end‑to‑end product traceability.

Turn-key Execution

We integrate labeling control, artwork coordination, and serialization capabilities within our packaging operations to support consistent, inspection‑ready execution.

Card 01

Market Compliance

Our team works hand in hand with yours to ensure approved artwork is accurately incorporated across products, formats, and markets.

Card 02

Print‑File Readiness

Print files are reviewed for GMP compliance and label readability to confirm accuracy and execution readiness prior to approval for use. 

Card 03

Supplier Coordination

Collaboration with qualified packaging suppliers ensures materials and components are selected and supplied within approved specifications.

Labeling and Serialization Capabilities

Groupe PARIMA’s labeling and serialization capabilities support accurate execution across regulated markets. Our technical approach combines packaging guidance, serialization control, traceability, and supplier coordination to ensure labeling operations remain aligned with client and regulatory expectations.

01
Card 01

Packaging Design Guidance

Technical guidance is provided on labeling and packaging layouts based on format constraints.

02
Card 03

Unit‑Level Serialization

Unique serial numbers are applied at the individual saleable unit level in alignment with defined serialization strategies.

03
Card 03

Full Aggregation Support

Serialization is supported with full aggregation across unit, bundle, case, and pallet packaging levels.

04
Card 04

Traceability Data Management

Traceability data is generated and managed for compatibility with client systems and third‑party track‑and‑trace providers.

05
Card 05

Regulatory Data Exchange

Serialized data is transmitted to support downstream regulatory traceability and product authentication.

Our Numbers

Our labeling and serialization metrics reflect the scale, regulatory reach, and operational consistency clients rely on when moving products to commercial supply.

5 to 2,500 kg

Batch Sizes

Creams, gels, and ointments manufactured across development, scale‑up, and commercial production.

20 to 4,000 kg

Batch Sizes

Liquids and suspensions produced at multiple scales to support clinical supply and commercial demand.

30M Units

Annual Capacity

High‑capacity manufacturing operations supporting sustained commercial production.

Labeling and serialization activities are executed in alignment with packaging specifications, serialized data requirements, and regulatory expectations from manufacturing to commercial distribution.

Resources

Our resources share practical insights on labeling and serialization to help clients make informed technical and regulatory decisions.

Groupe PARIMA
2026/04/27
How Drug Product Formulation Works: Topical, Oral, and Nasal Liquid and Semi-Solid Dosage Forms
Groupe PARIMA
2026/03/18
How Early API Characterization Can Reduce Formulation and Scale-up Risks
Groupe PARIMA
2025/10/23
Topical 101: A Guide to Complex Dermatology Formulation Development
Groupe PARIMA
2026/04/27
How Drug Product Formulation Works: Topical, Oral, and Nasal Liquid and Semi-Solid Dosage Forms
Groupe PARIMA
2026/03/18
How Early API Characterization Can Reduce Formulation and Scale-up Risks
Groupe PARIMA
2025/10/23
Topical 101: A Guide to Complex Dermatology Formulation Development

Contact Us

Discuss your labeling and serialization strategy

Let’s discuss how our integrated CDMO expertise supports compliant labeling and serialization execution from manufacturing through commercial distribution.